Advertisement
Traumatic injury is not a main driver for continued opioid use in patients who were not taking opioids prior to their injuries

ACS: Opioid Rx After Severe Injury Not Tied to Long-Term Use

0
Only 1 percent still took opioids one year after hospital discharge
Patients who knowingly took a placebo pill while undergoing traditional treatment for lower back pain had less pain and disability than those who received traditional treatment alone

Open-Label Placebo Treatments Can Ease Chronic Low Back Pain

0
Patients knew they were taking a placebo and still obtained relief, researchers say
Children 14 and younger require only two doses of the human papillomavirus vaccine rather than the previously recommended three doses

CDC: Two Doses of HPV Vaccine Sufficient for Children Under 15

0
But agency's revised guidelines still recommend three doses for 15- to 26-year-olds
Among patients with ureteral stones

Certain Factors Predict Repeat ER Visits for Ureteral Stones

0
Younger patients, having proximal stones, needing IV narcotics more likely to return
Lartruvo (olaratumab) has been approved by the U.S. Food and Drug Administration to treat adults with certain soft tissue sarcomas.

FDA Approves New Treatment for Advanced Soft Tissue Sarcoma

0
Sanctioned for use with doxorubicin in cases that cannot be treated with radiation or surgery
In pregnant women taking the antidepressant bupropion

Researchers Find Antidepressant Bupropion Crosses Placenta

0
Concentrations suggest higher fetal exposure to metabolites than the drug
Financial toxicity is a clinically relevant outcome for patients receiving treatment for advanced cancer

Financial Toxicity Is a Relevant Cancer Outcome Measure

0
Health-related quality of life correlated with financial toxicity in cancer patients
For patients with advanced retinoblastoma

Topotecan-Based Therapy Beneficial for Retinoblastoma

0
Findings show globe salvage with vision for topotecan plus vincristine, carboplatin, focal therapy
For patients with heart failure with preserved ejection fraction with an exercise-induced increase in the ratio between early mitral inflow velocity and mitral annular early diastolic velocity

Spironolactone Benefits Exercise Tolerance in HFpEF

0
Improvements in exercise capacity, anaerobic threshold, and oxygen uptake efficiency
For U.S. adults

Considerable Economic Burden for Vaccine-Preventable Diseases

0
Economic burden estimated at about $9 billion in 2015 for adults ages 19 years and older